Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2026 Poal.co

472

SEATTLE, March 10, 2020 – The Bill & Melinda Gates Foundation, Wellcome, and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term. Currently there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and none approved for use on COVID-19.

https://www.nowtheendbegins.com/bill-gates-gavi-vaccine-alliance-mastercard-truststamp-biometric-digital-identification-combined-with-vaccine-west-africa/ A biometric digital identity platform that “evolves just as you evolve” is set to be introduced in “low-income, remote communities” in West Africa thanks to a public-private partnership between the Bill Gates-backed GAVI vaccine alliance, MasterCard and the AI-powered “identity authentication” company, Trust Stamp.

SEATTLE, March 10, 2020 – The Bill & Melinda Gates Foundation, Wellcome, and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term. Currently there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and none approved for use on COVID-19. https://www.nowtheendbegins.com/bill-gates-gavi-vaccine-alliance-mastercard-truststamp-biometric-digital-identification-combined-with-vaccine-west-africa/ A biometric digital identity platform that “evolves just as you evolve” is set to be introduced in “low-income, remote communities” in West Africa thanks to a public-private partnership between the Bill Gates-backed GAVI vaccine alliance, MasterCard and the AI-powered “identity authentication” company, Trust Stamp.

(post is archived)

[–] • 1 pt

Big Pharma and the deep state media are hiding a Covid cure/treatment from all of us! Please copy and spread wide! The copy/paste from the site doesn't transfer well. This site is awesome and worth your time to review the data!

https://ivmmeta.com/

•98% of the 52 studies to date report positive effects (25 statistically significant in isolation). Random effects meta-analysis for early treatment and pooled effects shows an 81% reduction, RR 0.19 [0.09-0.38], and prophylactic use shows 85% improvement, RR 0.15 [0.09-0.25]. Mortality results show 76% lower mortality, RR 0.24 [0.14-0.42] for all treatment delays, and 84% lower, RR 0.16 [0.04-0.63] for early treatment.

•96% of the 27 Randomized Controlled Trials (RCTs) report positive effects, with an estimated 65% improvement, RR 0.35 [0.24-0.52].

•The probability that an ineffective treatment generated results as positive as the 52 studies to date is estimated to be 1 in 85 trillion (p = 0.000000000000012).

•All data to reproduce this paper and the sources are in the appendix. See [Bryant, Hill, Kory, Lawrie, Nardelli] for other meta analyses, all with similar results confirming effectiveness.

[–] • 1 pt

Patriot, seems like Ol' Bill has a printing press in his basement.

[–] • 1 pt

He's got a better one. A monopoly on operating systems and a foundation which protects his money from the tax man.

[–] • 0 pt

Who is Wellcome?

Where Wellcome's money comes from The original source of our funding was a bequest left by Sir Henry Wellcome on his death in 1936.

For the next 50 years, we were the sole owner of Wellcome Plc, the pharmaceutical company founded by Sir Henry. Dividends from the company funded the charitable grants we made for research. In 1986, we decided to diversify by listing and selling shares in the company, which was subsequently bought by the pharmaceutical company Glaxo in 1995.